Korea United Pharm Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Korea United Pharm Inc

Watchlist Manager

Watchlist

Price: 17 650 KRW -1.62%

Market Cap: ₩259.7B

	Korea United Pharm Inc KRX:033270	KR
K	Kyocera Corp DUS:KYR	JP
	Nanofilm Technologies International Ltd SGX:MZH	SG
	Parallel Industries Inc OTC:EAPH	CA
	Columbia Care Inc F:3LP	US

Profitability Summary

Korea United Pharm Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

55%

Strong 3Y Average Gross Margin

56%

Declining Gross Margin

57% > 55%

Healthy Operating Margin

17%

Sustainable 3Y Average Operating Margin

19%

Declining Operating Margin

20% > 17%

Healthy Net Margin

26%

Sustainable 3Y Average Net Margin

14%

Net Margin is Increasing

18% > 26%

Exceptional Free Cash Flow Margin

13%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

14% > 13%

Positive ROE

17%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

Declining ROIC

17% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.